Article
Macromolecules, Vol. 43, No. 9, 2010 4083
J = 6.8 Hz, (-CH3)), 2.70 (sx, 1H, J = 6.96 Hz (-Coxazoline
-
J = 7.6 Hz, 13.4
follow. 1H NMR (CDCl3, δ, ppm): 1.0-1.4 (br (-CH3)),
2.6-2.8 (br (-CHCH2S-)), 2.8-3.1 (br (-CCHCH3CH2-)),
CH(CH3)CH2-)), 2.934 (dd, 1H,
(-CHCHaHbS-)), 3.29 (dd, 1H, J1 = 6.4 Hz, J2=13.2 Hz
(-CHCHaHbS-), 3.77 (t, 2H, J = 9.6 Hz (-NCH2CH2O-)),
4.13 (t, 2H, J = 9.6 Hz (-NCH2CH2O-)), 7.16 (m, 1H, J = 7.2
Hz (Ar(H)), 7.26 (m, 2H, J = 7.0 Hz (Ar(H)), 7.35 (m, 2H, J =
6.0 Hz (Ar(H)). 13C NMR (CDCl3, δ, ppm): 18.5 (-CH3), 33.0
(-CoxazolineCHCH2S-), 38.0 (-CHCH2S-), 54.0 (-NCH2-
CH2O-), 68.0 (-NCH2CH2O-), 126.0 (Ar(C)), 129.0
(Ar(C)), 131.0 (Ar(C)), 136.0 (Ar(C)), 170.0. (-NdC-). IR:
1600 (Ar(CdC)), 1670 (NdC), 3080 (Ar(C-H)), 3050
(Ar(C-H).
Characterization of 2. The monomer 2 was isolated as its
racemate (yield 90%). 1H NMR (CDCl3, δ, ppm): 1.25 (d, 3H,
J = 6.4 Hz (-CH3)), 2.725 (dd, 2H, J1 = 6.4 Hz, J2 13.6 Hz
(-CHCH2S-)), 2.94 (m, 1H, J =6.56 (CoxazolineCHCH3CH2-)),
3.23 (s, 2H (-SCH2COOC3)), 3.71, (s, 3H (-COOCH3)), 3.82 (t,
2H, J = 9.6 Hz (-NCH2CH2O-)), 4.22 (t, 2H, J = 9.2 Hz
(-NCH2CH2O-). 13C NMR (CDCl3, δ, ppm): 17.0 (-CH3),
34.0 (-CoxazolineCHCH2S-), 34.0 (-CHCH2S-), 37.0 (-SCH2-
COOCH3), 52.0(-COOCH3), 54.0 (-NCH2CH2O-), 67.5
(-NCH2CH2O-), 170.0 (-NC-), 171.0 (-CH2COOCH3). IR:
1250 (ester (O-C)), 1670 (NdC), 1740 (CdO).
Characterization of 3. The monomer 3 was isolated as its
racemate (yield 97%). 1H NMR (CDCl3, δ, ppm): 1.23 (d, 3H,
J = 6.28 Hz (-CH3)), 1.425 (s, 9H (-OC(CH3)3)), 2.64 (m, 2H
(CoxazolineCHCH2S-)), 2.84 (m, 1H, (CoxazolineCHCH3CH2-)),
2.95 (d, 2H, J = 4.8 Hz (-SCH2CH-)), 3.70 (s, 3H
(-COOCH3)), 3.82 (t, 2H, J = 9.6 Hz (-NCH2CH2O-)),
4.22 (t, 2H, J = 9.6 Hz (-NCH2CH2O-)), 4.51 (m, 1H
(-CH2-NHCHCOOCH3). 13C NMR (CDCl3, δ, ppm): 17.0
(-CH3), 28.0 (-OC(CH3)3), 34.0 (-CoxazolineCHCH3CH2S-),
35.0 (-CoxazolineCHCH3CH2S-), 37.0 (-SCH2CH), 52.5
(-COOCH3), 54.0 (-SCH2CHCOOCH3), 54.3 (-NCH2-
CH2O-), 67.5 (-NCH2CH2O-), 80.0 (-NHCOOC(CH3)3),
155.5 (-NHCOOC-), 170.0 (-NC-), 172.0 (-CCOOCH3).
IR: 1250 (ester (O-C)), 1670 (NdC), 1720 (CdO), 1760
(carbamate (O = C)), 3200 (N-H), 3350 (N-H).
General Procedure for the Polymerization of Functionalized 2-
Isopropenyl-2-oxazoline. The desired 2-isopropenyl-2-oxazoline
functionalized monomer was dried under vacuum overnight to
remove any water. All glassware was flame-dried. Distilled
acetonitrile (4-6 mL) was added to the reaction flask under
N2 gas with a syringe. Varying initiator to monomer ratios were
studied including 1:50, 1:100, 1:150, and 1:200. In this example,
an initiator to monomer ratio of 1:100 was employed. Distilled
methyl tosylate (0.0126 g, 0.0678 mmol) was added to the
reaction via syringe. Functionalized 2-isopropenyl-2-oxazoline
monomer (e.g., monomer 1, 1.5 g, 6.785 mmol) was added
via syringe, and the reaction was stirred for 24 h at 70 °C. After
24 h the reaction was cooled in an ice bath, and 0.5 mL of H2O
was added and stirred overnight at room temperature.
The polymer was precipitated into diethyl ether and filtered.
The polymer was washed with NaHCO3 to remove any tosylate
anion (conversion: 19%).
3.1-3.8 (br (-NCH2CH2-)), 6.9-7.4 (br (CH from (Ph))). 13
C
NMR (CDCl3, δ, ppm): 19 (-CH3), 37 (-CCHCH3CH2-), 38
(-CHCH2S-), 48 (-NCH2CH2-), 126 (Ar(C)), 137 (Ar(C)),
139 (Ar(C)), 146 (Ar(C)), 186 (-NCOCH-). IR: 1600
(Ar(CdC)), 1640 (tertiary amide(C-N)), 3050 (Ar(C-H),
3080 (Ar(C-H)), 3300 (O-H), 3500 (O-H).
Characterization of 5. MALDI-TOF MS was taken at a
matrix/counterion/sample ratio of 1:2:1, with 1,8,9-anthracene-
triol matrix (20 mg/mL), NaTFA (2 mg/mL) as the counterion,
and 2 mg/mL of sample. Representative characterization data
follow. 1H NMR (CDCl3, δ, ppm): 1.10-1.30 (br (-CH3)),
2.55-2.70 (br (-CHCH2S-)), 2.85-3.10 (br (-CCHCH3CH2-)),
3.10-3.30 (br (-SCH2C-)), 3.40-3.60 (br (-NCH2CH2-))
3.60-3.75 (br (-COOCH3)). 13C NMR (CDCl3, δ, ppm): 19
(-CH3), 34 (-CCHCH3CH2-), 36 (-CCH2S-), 37 (-SCH2CO-
OCH3), 46 (-NCH2CH2-), 52 (-COOCH3), 172 (-CH2COO-
CH3), 176 (-NCOC-). IR: 1640 (tertiary amide (C-N)), 1735
(ester (CdO)), 3500 (O-H), 3200 (O-H).
For the purification of polymer 5f (Table 1), a different work-
up was employed to isolate the highest molecular weight fraction
of the polymer. The above-described polymerization procedure
was employed with a 1:130 initiator (0.0132 g, 0.0709 mmol) to
monomer (monomer 2, 2 g, 9.2133 mmol) ratio with acetonitrile
as solvent (4 mL) followed by the addition of H2O (0.5 mL),
precipitation in diethyl ether, filtration, and wash (conversion:
14%); Mn (GPC, before collection of high molecular weight
fraction): 4000. The polymer (0.1500 g, 0.0375 mmol) was then
dissolved in toluene (150 mL) with a small amount of dichlor-
omethane (25 mL). Diethyl ether was then added dropwise until
cloudy (∼50 mL). The solution was then heated using a hot air
gun until clear and allowed to precipitate overnight overnight.
The precipitate was then collected. This was repeated twice
(overall yield: 4.8%).
Characterization of 6. MALDI-TOF MS was taken at a
matrix/counterion/sample ratio of 1:0.7:1, with galvinoxyl, free
radical (10 mg/mL) matrix, NaTFA (2 mg/mL) as the counter-
ion, and 2 mg/mL of sample. Representative characterization
data follow. 1H NMR (CDCl3, δ, ppm): 1.00-1.20 (br (-CH3)),
1.25-1.50 (br (-C(CH3)3)), 2.40-2.65 (br (-CHCH2S-)),
2.65-3.10 (br (-CCHCH3CH2-)); (-SCH2CH-), 3.40-3.60
(br (-NCH2CH2-)), 3.61-3.78 (br (-COOCH3)), 4.35-4.55
(br (-SCH2CH-)). 13C NMR (CDCl3, δ, ppm): 19.0 (-CH3),
29.0 (C(CH3)3), 35.0 (-CHCH2S-), 37.0 (-CHCH2S-), 39.0
(-SCH2CH-), 44.0 (-NCH2CH2-), 52.0 (-COOCH3), 54.0
(-SCH2CH-), 81.0 (-COOC(CH3)3), 156.0 (-NHCOOC-
(CH3)3), 171.5 (-CHCOOCH3-), 177.0 (-NCOOCH-). IR:
1640 (tertiary amide (-N-)), 1710 (C-O), 1760 (carbamate
(OdC)), 3350 (O-H, N-H), 3200 (O-H, N-H).
Deprotection of Carboxylic Acid Functionality of 5. Ammo-
nium hydroxide (3 mL) was added to methyl thioglycolate
functionalized 2-isopropenyl-2-oxazoline polymer (25 mg,
5.6818 mmol) in a 5 mL vial. The vial was then capped and heated
in a sand bath at 90 °C overnight. The ammonium hydroxide and
any water present were then evaporated, and the sample was
further dried under vacuum. Representative characterization data
follow. 1H NMR (D2O, δ, ppm): 1.20-1.26 (br (-CH3)),
2.60-2.80 (br (-CHCH2S-)), 2.80-2.90 (br (-CCHCH3CH2-)),
3.00-3.20 (br (-SCH2C-)), 3.20-3.60 (br (-NCH2CH2-)). 13C
NMR (CD3OD, δ, ppm): 19.0 (-CH3), 36.0 (-CCHCH3CH2-),
37.0 (-CCH2S-), 37.5 (-SCH2COOCH3), 48.0 (-NCH2CH2-),
175.0 (-CH2COOH), 178.5 (-NCOC-). IR: 1640 (tertiary amide
(C-N)), 1660 (ester (CdO)), 3500 (O-H), 3200 (O-H), 3310
(O-H).
For the determination of monomer conversion versus molec-
ular weight, the polymerization procedure described above was
employed with a 1:130 initiator (0.0129 g, 0.0696 mmol) to
monomer (monomer 1, 2 g, 9.0462 mmol) ratio with acetonitrile
as solvent (4 mL). The reaction was heated to 65 °C. Aliquots
(0.25 mL) of the bulk reaction were removed every 2 h with a
disposable syringe. The samples were cooled in an ice bath, and
0.1 mL of H2O was added. The sample was then concentrated to
remove acetonitrile with a rotary evaporator. No further pur-
ification was preformed on the samples before acquiring GPC
data (Figure 7).
Deprotection of Carboxylic Acid Functionality of 6. Ammo-
nium hydroxide (3 mL) was added to N-(tert-butoxycarbonyl)-
L-cysteine methyl ester functionalized 2-isopropenyl-2-oxazo-
line polymer (25 mg, 3.5714 mmol) in a 5 mL vial. The vial
was then capped and heated in a sand bath at 90 °C overnight.
Characterization of 4. MALDI-TOF MS was taken at a
matrix/counterion/sample ratio of 1:1:1, with 1,8,9-anthracene-
triol matrix (20 mg/mL), NaTFA (2 mg/mL) as the counterion,
and 2 mg/mL of sample. Representative characterization data